Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -689 | -8,360 | -5,484 | -2,472 | -909 |
| Depreciation Amortization | N/A | 1,020 | 898 | 598 | 295 |
| Other Working Capital | -487 | 580 | 190 | -222 | -125 |
| Other Operating Activity | -1,136 | 1,550 | 600 | 234 | -209 |
| Operating Cash Flow | $-2,312 | $-5,210 | $-3,796 | $-1,862 | $-948 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -2 | -2 | -1 | -1 |
| Investing Cash Flow | $-1 | $-2 | $-2 | $-1 | $-1 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -65 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 5,130 | 660 | 660 | 660 |
| Other Financing Activity | 0 | -10 | 0 | 0 | 0 |
| Financing Cash Flow | $-65 | $5,120 | $660 | $660 | $660 |
| Beginning Cash Position | 5,619 | 5,700 | 5,704 | 5,704 | 5,704 |
| End Cash Position | 3,240 | 5,610 | 2,567 | 4,501 | 5,415 |
| Net Cash Flow | $-2,379 | $-80 | $-3,137 | $-1,203 | $-289 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,312 | -5,210 | -3,796 | -1,862 | -948 |
| Capital Expenditure | -1 | -2 | -2 | -1 | -1 |
| Free Cash Flow | -2,313 | -5,212 | -3,797 | -1,863 | -949 |